The Leadership Team at AbolerIS Pharma consists of the CEO, three Founders, and the CFO. This team is responsible for setting the strategic direction of the company, ensuring financial stability, and fostering innovation in developing unique therapeutic approaches to induce immune tolerance. They leverage their extensive expertise in regulatory T cells and mechanisms of tolerance to steer AbolerIS Pharma towards its goal of addressing inflammatory, autoimmune, and degenerative diseases.